10月24日 - ** 药物开发商Coya Therapeutics的COYA.O股价盘前下跌14%至6.01美元
** COYA宣布在 (link)，定价为2000万美元。
** 公司以每股5.50美元的价格出售360万股股票，比股票最后收盘价折价21%。
** Lucid Capital Markets是公开发行股票的唯一簿记管理人
** 根据招股说明书，截至 6 月 30 日，COYA 共有 1670 万股流通股 (link)
** 募集资金将用于临床开发计划和其他用途
** 截至上次收盘，COYA股价年累计上涨21.8%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.